MEN1 Gene Mutation and Reduced Expression Are Associated With Poor Prognosis in Pulmonary Carcinoids

Swarts, Dorian R. A.; Scarpa, Aldo; Corbo, Vincenzo; Van Criekinge, Wim; van Engeland, Manon; Gatti, Gaia; Henfling, Mieke E. R.; Papotti, Mauro; Perren, Aurel; Ramaekers, Frans C. S.; Speel, Ernst-Jan M.; Volante, Marco (2014). MEN1 Gene Mutation and Reduced Expression Are Associated With Poor Prognosis in Pulmonary Carcinoids. Journal of clinical endocrinology and metabolism, 99(2), E374-E378. Endocrine Society 10.1210/jc.2013-2782

[img] Text
jc.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (336kB) | Request a copy

Context: MEN1 gene alterations have been implicated in lung carcinoids, but their effect on gene expression and disease outcome is unknown. Objective: Our objective was to analyze MEN1 gene and expression anomalies in lung neuroendocrine neoplasms and their correlations with clinicopathologic data and disease outcome. Design: We examined 74 lung neuroendocrine neoplasms including 58 carcinoids and 16 high-grade neuroendocrine carcinomas (HGNECs) for MEN1 mutations (n = 70) and allelic losses (n = 69), promoter hypermethylation (n = 65), and mRNA (n = 74) expression. Results were correlated with disease outcome. Results: MEN1 mutations were found in 7 of 55 (13%) carcinoids and in 1 HGNEC, mostly associated with loss of the second allele. MEN1 decreased expression levels correlated with the presence of mutations (P = .0060) and was also lower in HGNECs than carcinoids (P = .0024). MEN1 methylation was not associated with mRNA expression levels. Patients with carcinoids harboring MEN1 mutation and loss had shorter overall survival (P = .039 and P = .035, respectively) and low MEN1 mRNA levels correlated with distant metastasis (P = .00010) and shorter survival (P = .0071). In multivariate analysis, stage and MEN1 allelic loss were independent predictors of prognosis. Conclusion: Thirteen percent of pulmonary carcinoids harbor MEN1 mutation associated with reduced mRNA expression and poor prognosis. Also in mutation-negative tumors, low MEN1 gene expression correlates with an adverse disease outcome. Hypermethylation was excluded as the underlying mechanism.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Perren, Aurel

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

0021-972X

Publisher:

Endocrine Society

Language:

English

Submitter:

Andrea Arnold

Date Deposited:

02 Apr 2014 14:55

Last Modified:

10 Sep 2015 09:33

Publisher DOI:

10.1210/jc.2013-2782

PubMed ID:

24276465

BORIS DOI:

10.7892/boris.45136

URI:

https://boris.unibe.ch/id/eprint/45136

Actions (login required)

Edit item Edit item
Provide Feedback